NOVEL CELL LINES AND AI DIGITAL MANUFACTURING PLATFORM
TO IMPROVE HUMAN WELL-BEING
BIOINFORMATIC/AI SERVICES
TO REDUCE CELL MEDIA COSTS, INCREASE CELL TISSUE FORMATION
NOVEL STEM CELL LINES (iPSCs)
TO SCALE-UP PRODUCTION, INCREASE CELL BIOMASS YIELDS
DRUG DEVELOPMENT
DRUG DEVELOPMENT
DRUG DEVELOPMENT
DEVELOP EFFICIENT HUMAN DISEASE MODELS AND REDUCE PRECLINICAL AND CLINICAL COSTS
- Human iPSCs that retain pluripotency in time
- Fully functional tissue potential
- Platform to develop any human disease model
- Increase the predictive power at preclinical stages
- Reduce drug candidates, reduce clinical costs
CULTIVATED MEAT
DRUG DEVELOPMENT
DRUG DEVELOPMENT
TRANSFORM THE ECONOMICS AND
SCALE-UP PRODUCTION
- Multispecies iPSCs
- High-yielding biomass, non-GMO
- All meat tissues at scale
- 100x cell media cost reduction services
- Cell tissue optimization services
OUR PARTNERS AND ADVISORS
CHALLENGE
CURRENT CELL LINES ARE INEFFICIENT
LOW CELL VIABILITY: CELL CULTURE NOT SCALABLE
RAPID LOSS OF PLURIPOTENCY: NOT PROVIDING ALL TISSUES AT LARGE SCALE PRODUCTION
POOR TISSUE FUNCTIONALITY: FAILURE TO CAPTURE COMPLEXITY OF ORGANS
HIGH CELL MEDIA COSTS: MAIN CELL CULTURE COST DRIVER
LACK OF STEM CELL BIG DATA: TO DEVELOP TRUSTWORTHY AI AND PREDICT BEHAVIOUR
OUR SOLUTION
NOVEL METHOD TO DEVELOP HIGHLY VIABLE AND FUNCTIONAL STEM CELL LINES AT LARGE SCALE EFFICIENTLY
NEWSLETTER
CONTACT US
NOVEL STEM CELL LINES & AI DIGITAL MANUFACTURING
Copyright © 2023 Alt Atlas, Stem cells and AI Platform Technology - All rights reserved